DeMuth Peter 4
4 · Elicio Therapeutics, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-01+342→ 342 totalExercise: $4.50Exp: 2034-02-01→ Common Stock (342 underlying) - Award
Stock Option (right to buy)
2024-02-01+29,800→ 29,800 totalExercise: $4.50Exp: 2034-02-01→ Common Stock (29,800 underlying)
Footnotes (2)
- [F1]Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
- [F2]The stock options vested in full on February 1, 2024.